510(k) · Cleared
ClearedC. Diff Quik Chek
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Techlab, Inc. · MCB Antigen, C. Difficile
Cleared on Apr 26, 2006 as substantially equivalent to K030992 (Techlab, Inc., 2003) and 4 other predicates after a 125-day review. Its family tree reaches back 1 generation to 1987. 3 later devices descend from it.
- Decided
- Apr 26, 2006
- Review
- 125 days
- Class
- Class I
- Product code
- MCB
- Recalls
- None
- Predicates
- 5
Its longest line of descent runs back 1 generation to K870864 (1987). 5 ancestors in all. 3 later devices descend from it, 3 citing it directly.
- Root · 1 generation backK870864 Culturette Brand CDT Clostridium Difficile TestMarion Laboratories, Inc. · 1987
- This deviceK053572 C. Diff Quik ChekTechlab, Inc. · 2006
- Descendant · cites it directly · 0 of its ownK132010 Vidas C Difficile GDHBiomerieux S.A. · 2013
- Descendant · cites it directly · 0 of its ownK112048 Immunocard C. Difficile GDHMeridian Bioscience, Inc. · 2011
- Descendant · cites it directly · 0 of its ownK082499 C. Diff Quik Chek CompleteTechlab, Inc. · 2009
Most influential descendants
Showing 3 of 3 · See allView FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K870864 | Culturette Brand CDT Clostridium Difficile Test | Marion Laboratories, Inc. | 1987 | — |
| 0 (this device) | K053572 | C. Diff Quik Chek | Techlab, Inc. | 2006 | — |
| +1 | K132010 | Vidas C Difficile GDH | Biomerieux S.A. | 2013 | — |
| +1 | K112048 | Immunocard C. Difficile GDH | Meridian Bioscience, Inc. | 2011 | — |
| +1 | K082499 | C. Diff Quik Chek Complete | Techlab, Inc. | 2009 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1993 | 1 | 0 |
| 1998 | 1 | 0 |
| 2003 | 2 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2009 | 1 | 0 |
| 2011 | 1 | 0 |
| 2013 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in MCB? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (6)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K030992 | C. Diff Chek - 60Summary page 1…C. difficile Culture media such as cycloserine - cefoxitin fructose agar (CCFA) is available commercially from various sources. * C. DIFFCHEKIm - 60 (K03 0992) - TECHLAB®, Inc. (Blacksburg, VA) * C. DIFFCHEKYm- 30 (K03099 1) - TEcHLAB®, Inc. (Blacksburg, VA) * BD CULTUR… | 2003 |
| * | K030991 | C. Diff Chek - 30Summary page 1…CCFA) is available commercially from various sources. * C. DIFFCHEKIm - 60 (K03 0992) - TECHLAB®, Inc. (Blacksburg, VA) * C. DIFFCHEKYm- 30 (K03099 1) - TEcHLAB®, Inc. (Blacksburg, VA) * BD CULTURETTETM CDTTM (K870864) - Becton, Dickinson and Company (Frankli… | 2003 |
| * | K870864 | Culturette Brand CDT Clostridium Difficile TestSummary page 1…DIFFCHEKIm - 60 (K03 0992) - TECHLAB®, Inc. (Blacksburg, VA) * C. DIFFCHEKYm- 30 (K03099 1) - TEcHLAB®, Inc. (Blacksburg, VA) * BD CULTURETTETM CDTTM (K870864) - Becton, Dickinson and Company (Franklin Lakes, NJ) * Triage®)Micro Clostridiumn difficile Panel (K974881)… | 1987 |
| * | K974881 | Triage C. Difficile, Triage C. Difficile Panel, Triage C. Difficile Toxin aSummary page 1…rg, VA) * BD CULTURETTETM CDTTM (K870864) - Becton, Dickinson and Company (Franklin Lakes, NJ) * Triage®)Micro Clostridiumn difficile Panel (K974881) - Biosite Incorporated (San Diego, CA) * InmmuoCardo C. difficile FIA (K924979) - Meridian Bioscience, Inc.… | 1998 |
| * | K924979 | Immunocard (TM) C. DifficileSummary page 1…lin Lakes, NJ) * Triage®)Micro Clostridiumn difficile Panel (K974881) - Biosite Incorporated (San Diego, CA) * InmmuoCardo C. difficile FIA (K924979) - Meridian Bioscience, Inc. (Cincinnati, OH) Inlended Use *The C. DIFFQUIK CHEKTM test is a rapid membrane e… | 1993 |
| * | — | C. difficile Presumptive bacterial culture Named without a submission number |
What descends from it? (3)
3 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
How does its category compare?
All MCB devicesMCB Antigen, C. Difficile: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · MCB
1in 2013
2026 to Oct 25, outlined.
Median 510(k) review, days · MCB
Too few MCB 510(k)s in any year since 2007 to give a median.
Recalls per year · MCB
1in 2021
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · MCB
2in 2023
MAUDE reports naming product code MCB, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 1 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 2 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 1 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 0 | — | 0 | 3 |
| 2019 | 0 | — | 0 | 0 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 0 | — | 1 | 2 |
| 2022 | 0 | — | 0 | 2 |
| 2023 | 0 | — | 0 | 2 |
| 2024 | 0 | — | 0 | 0 |
| 2025 | 0 | — | 0 | 0 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The C. DIFF QUIK CHEK™ test is a rapid membrane enzyme immunoassay for use as a screening test to detect Clostridium difficile antigen, glutamate dehydrogenase, in fecal specimens from persons suspected of having C. difficile disease. The test does not distinguish toxigenic from nontoxigenic strains of C. difficile. With the use of additional tests that detect C. difficile toxins, the test is to be used as an aid in the diagnosis of C. difficile disease. As with other C. difficile tests, results should be considered in conjunction with the patient history.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K053572 · printed Nov 4, 2026
Cite this page
510(k) Report. “K053572: C. Diff Quik Chek.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K053572
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026